New gel shows promise for diabetic wound healing
NCT ID NCT06608303
First seen Nov 17, 2025 · Last updated Jun 21, 2026 · Updated 22 times
Summary
This study tested a gel containing a protein called GM-CSF on 40 people with diabetic wounds that were in the healing (granulation) phase. The gel aims to boost the body's own repair cells to help wounds close faster. Researchers measured how much the wound size shrank and checked for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC WOUND are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
human granulocyte macrophage stimulating factor gel (JinFuNing)
What this could lead to
If it works, this gel could speed up healing of diabetic wounds, reducing infection risk and improving quality of life.
What could go wrong
This is a small, completed study with only 40 participants. The results may not apply to all diabetic wounds, and the gel may not work better than standard care.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.